Target intelligence / Profile preview

Ribosomal protein L6 pseudogene 11 (RPL6P11)

Target: RPL6P11
Molecular classification: Pseudogene

Overview

Ribosomal protein L6 pseudogene 11 (RPL6P11) is a processed pseudogene in the human genome. It is related by sequence homology to the ribosomal protein L6 gene (RPL6), but does not encode a functional protein. Pseudogenes such as RPL6P11 result from gene duplication or retrotransposition events, and generally lack the regulatory or coding elements required for protein synthesis. RPL6P11 has no known molecular, biochemical, or disease-related function. It is not a therapeutic target or biomarker, and there are no documented interactions with drugs or biological pathways[7].

Beyond the preview

Go deeper on Ribosomal protein L6 pseudogene 11 (RPL6P11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L6 pseudogene 11 (RPL6P11).

Explore the full profile